Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Before High-Dose Chemotherapy BEAM With Autologous Stem Cell Transplantation (ASCT)
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Obinutuzumab (Primary) ; Cisplatin; Cytarabine; Dexamethasone; Pegfilgrastim
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Acronyms GIOTTO
- 07 Feb 2018 Status changed from suspended to discontinued.
- 28 Dec 2017 Status changed from recruiting to suspended.
- 10 Jun 2017 Biomarkers information updated